BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 9766664)

  • 1. Reduction of dimesna to mesna by the isolated perfused rat liver.
    Goren MP; Hsu LC; Li JT
    Cancer Res; 1998 Oct; 58(19):4358-62. PubMed ID: 9766664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and metabolism of sodium 2-mercaptoethanesulfonate in the rat.
    Ormstad K; Orrenius S; LĂ„stbom T; Uehara N; Pohl J; Stekar J; Brock N
    Cancer Res; 1983 Jan; 43(1):333-8. PubMed ID: 6401168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects.
    Goren MP; Houle JM; Bush DA; Li JT; Newman CE; Brade WP
    Clin Cancer Res; 1998 Oct; 4(10):2313-20. PubMed ID: 9796960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic and non-enzymatic mechanisms of dimesna metabolism.
    Cutler MJ; Velenosi TJ; Bodalia A; House AA; Urquhart BL; Freeman DJ
    Amino Acids; 2015 Mar; 47(3):511-23. PubMed ID: 25488427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of gemfibrozil and gemfibrozil acyl glucuronide in the rat isolated perfused liver.
    Sallustio BC; Fairchild BA; Shanahan K; Evans AM; Nation RL
    Drug Metab Dispos; 1996 Sep; 24(9):984-9. PubMed ID: 8886608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroid metabolism in isolated perfused rat liver and kidney. Experimental studies with emphasis on aldosterone.
    Egfjord M
    Acta Physiol Scand Suppl; 1995; 627():1-42. PubMed ID: 8848946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of amphotericin B in the isolated perfused rat liver.
    Hong Y; Ramzan I; McLachlan AJ
    J Pharm Pharmacol; 2004 Jan; 56(1):35-41. PubMed ID: 14979999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic disposition of cyclosporine A in isolated perfused rat livers.
    Mehvar R; Chimalakonda AP
    J Pharm Pharm Sci; 2004 Feb; 7(1):47-54. PubMed ID: 15144734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bimolecular glutathione conjugation kinetics of ethacrynic acid in rat liver: in vitro and perfusion studies.
    Tirona RG; Pang KS
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1230-41. PubMed ID: 10454499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dl-propranolol on lidocaine disposition in the perfused rat liver.
    Vu VT; Chen CP
    Drug Metab Dispos; 1982; 10(4):350-5. PubMed ID: 6126333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic clearance and biliary secretion of protoporphyrin in the isolated, in situ-perfused rat liver.
    Avner DL; Berenson MM
    J Lab Clin Med; 1982 Jun; 99(6):885-94. PubMed ID: 7077129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha-Bromoisovalerylurea as model substrate for studies on pharmacokinetics of glutathione conjugation in the rat. II. Pharmacokinetics and stereoselectivity of metabolism and excretion in vivo and in the perfused liver.
    te Koppele JM; Dogterom P; Vermeulen NP; Meijer DK; van der Gen A; Mulder GJ
    J Pharmacol Exp Ther; 1986 Dec; 239(3):905-14. PubMed ID: 3795049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselectivity in glutathione conjugation and amidase-catalyzed hydrolysis of the 2-bromoisovalerylurea enantiomers in the single-pass perfused rat liver.
    Polhuijs M; Gasinska I; Cherry WF; Mulder GJ; Pang KS
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1406-12. PubMed ID: 8510017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of mesna and dimesna after simultaneous intravenous bolus and infusion administration in patients undergoing bone marrow transplantation.
    el-Yazigi A; Ernst P; al-Rawithi S; Legayada E; Raines DA
    J Clin Pharmacol; 1997 Jul; 37(7):618-24. PubMed ID: 9243355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of preconditioning with N-acetylcysteine against reperfusion injury after prolonged cold ischaemia in rats liver in which glutathione had been reduced by buthionine sulphoximine.
    Nagasaki H; Nakano H; Boudjema K; Jaeck D; Alexandre E; Baek Y; Kitamura N; Yamaguchi M; Kumada K
    Eur J Surg; 1998 Feb; 164(2):139-46. PubMed ID: 9537722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic disposition and effects of nitric oxide donors: rapid and concentration-dependent reduction in the cytochrome P450-mediated drug metabolism in isolated perfused rat livers.
    Vuppugalla R; Mehvar R
    J Pharmacol Exp Ther; 2004 Aug; 310(2):718-27. PubMed ID: 15051803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier-mediated entry of 4-methylumbelliferyl sulfate: characterization by the multiple-indicator dilution technique in perfused rat liver.
    Chiba M; Schwab AJ; Goresky CA; Pang KS
    Hepatology; 1998 Jan; 27(1):134-46. PubMed ID: 9425929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competing pathways in drug metabolism. I. Effect of input concentration on the conjugation of gentisamide in the once-through in situ perfused rat liver preparation.
    Morris ME; Yuen V; Tang BK; Pang KS
    J Pharmacol Exp Ther; 1988 May; 245(2):614-24. PubMed ID: 3367309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of carbamazepine and its 10,11-epoxide metabolite in the isolated perfused rat liver.
    Rane A; Shand DG; Wilkinson GR
    Drug Metab Dispos; 1977; 5(2):179-84. PubMed ID: 15811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible (enzymatic) routes and biological sites for metabolic reduction of BNP7787, a new protector against cisplatin-induced side-effects.
    Verschraagen M; Boven E; Torun E; Hausheer FH; Bast A; van der Vijgh WJ
    Biochem Pharmacol; 2004 Aug; 68(3):493-502. PubMed ID: 15242815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.